Phase III data showed Cosentyx can provide rapid relief from symptoms of hidradenitis suppurativa as early as Week 2
The US Food and Drug Administration...
Novartis on Wednesday (February 1) predicted that core operating income would grow in a "mid single digit" percentage range in 2023 following stagnation last year,...
The Swiss competition commission (COMCO) has opened an investigation of Novartis over possible unlawful use of a patent to reduce competitive pressure, the Swiss...